Status:

COMPLETED

Use of Virtual Reality Mask or Music Therapy for Analgesia and Anxiolytic Purpose When Totally IVAD for Chemotherapy Under Local Anesthesia

Lead Sponsor:

Institut Curie

Conditions:

Implanted Venous Access Device

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Evaluate 2 medical devices on pain average and/or anxiety average in the totally Implanted Venous Access Device (IVAD) procedure under local anesthesia.

Detailed Description

Evaluate the efficacy of virtual reality and music therapy on pain average and/or anxiety average in the totally Implanted Venous Access Device (IVAD) procedure under local anesthesia.

Eligibility Criteria

Inclusion

  • Patient aged between 18 and 85 years.
  • Patient with cancer care and having a totally Implanted Venous Access Device (IVAD) procedure under local anesthesia for chemotherapy.
  • Absence of anxiolytic premedication.
  • Patient affiliated to social insurance.
  • Absence of contra-indication to the use of virtual reality, music therapy instrument or local lidocaine anesthesia.
  • Signed informed consent form.

Exclusion

  • Patient already participated to this study.
  • Patient deprived of liberty or under legal representative or under curatorship.
  • Psychiatric disease enabling communication.
  • Deafness or visual impairement.
  • Patient under beta-blockers medication.
  • Chronic pain present and not equilibrated before the measured procedure as \> 3 by the NRS.
  • Tracheotomy.
  • Low cervical tumor, or bilateral low cervical adenopathies.
  • Compression or jugular stenosis (uni or bilateral).
  • Jugular or subclavian thrombosis.
  • Patient under anticoagulants medication or having hesmostasis troubles.
  • Claustrophobia or thalassophobia inducing the possibility of rejecting the virtual reality mask or music therapy mask.
  • Patients not speaking french.
  • Pregnant and breastfeeding women.

Key Trial Info

Start Date :

December 6 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 16 2023

Estimated Enrollment :

127 Patients enrolled

Trial Details

Trial ID

NCT04804735

Start Date

December 6 2022

End Date

August 16 2023

Last Update

July 4 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Institut Curie

Paris, France, 75005

2

Institut Curie

Saint-Cloud, France, 92210

3

Gustave Roussy

Villejuif, France, 94805